Key facts
- This page summarizes John J. Alam's Form 4 filing for CervoMed Inc. (CRVO).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 13 Feb 2026, 17:00.
John J. Alam - 11 Feb 2026 Form 4 Insider Report for CervoMed Inc. (CRVO)
- Reporting relationship
- CEO & President, Director, 10%+ Owner
- Issuer ticker
- CRVO
- Reported as of
- 11 Feb 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 13 Feb 2026, 17:00:22 UTC
- Prior SEC filing
- 19 Nov 2025
- Next SEC filing
- 10 Jun 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ William R. Elder, attorney-in-fact for the Reporting Person
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
John J. Alam filed Form 4 for CervoMed Inc. (CRVO) on 13 Feb 2026.
Change
- Previous filing in this sequence was filed on 19 Nov 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001197014
Primary reporting owner
ALAM JOHN J
- Relationship
- CEO & President, Director, 10%+ Owner
- Address
- 20 PARK PLAZA, SUITE 424, BOSTON
- Signature
- /s/ William R. Elder, attorney-in-fact for the Reporting Person
- Signature date
- 13 Feb 2026
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CRVO
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +75,000
- Change %
- Price
- $0.000000
- Shares after
- 75,000
- Date
- 11 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 75,000
- Exercise price
- $4.80
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing February 28, 2026.